Form 8-K - Current report:
SEC Accession No. 0001213900-21-025416
Filing Date
2021-05-10
Accepted
2021-05-10 17:24:54
Documents
2
Period of Report
2021-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140542-8k_aditxtherap.htm 8-K 19817
2 LEASE AGREEMENT, DATED AS OF MAY 4, 2021, BY AND BETWEEN LS BIOTECH EIGHT, LLC, ea140542ex10-1_aditxtherap.htm EX-10.1 481403
  Complete submission text file 0001213900-21-025416.txt   502453
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 21908587
SIC: 2834 Pharmaceutical Preparations